Trial Outcomes & Findings for L-Carnitine in Peritoneal Dialysis (NCT NCT00922701)

NCT ID: NCT00922701

Last Updated: 2010-02-23

Results Overview

The amount of fluid recovered from the peritoneum at the end of the nocturnal exchange (long dwell) with a peritoneal dialysis solution.

Recruitment status

COMPLETED

Study phase

PHASE2

Target enrollment

4 participants

Primary outcome timeframe

day 5

Results posted on

2010-02-23

Participant Flow

From June, 2004, to November, 2004. Medical Clinic

One-week run-in

Participant milestones

Participant milestones
Measure
Peritoneal Dialysis Solution
Patients were treated with a glucose-based (1.5% weight/volume) peritoneal dialysis solution containing L-carnitine (0.25% weight/volume) for the long dwell. Peritoneal dialysis solution was instilled for 5 days.
Overall Study
STARTED
4
Overall Study
COMPLETED
4
Overall Study
NOT COMPLETED
0

Reasons for withdrawal

Withdrawal data not reported

Baseline Characteristics

L-Carnitine in Peritoneal Dialysis

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
Peritoneal Dialysis Solution
n=4 Participants
The enrolled patients were using for the long dwell (nocturnal) exchange a glucose-based (2.5% w/v) peritoneal dialysis solution.
Age Continuous
61.6 years
STANDARD_DEVIATION 11.9 • n=5 Participants
Sex: Female, Male
Female
1 Participants
n=5 Participants
Sex: Female, Male
Male
3 Participants
n=5 Participants
Region of Enrollment
Italy
4 participants
n=5 Participants
Ultrafiltration
1987 milliliters
STANDARD_DEVIATION 192 • n=5 Participants

PRIMARY outcome

Timeframe: day 5

The amount of fluid recovered from the peritoneum at the end of the nocturnal exchange (long dwell) with a peritoneal dialysis solution.

Outcome measures

Outcome measures
Measure
Peritoneal Dialysis Solution
n=4 Participants
Patients were treated with a glucose-based (1.5% weight/volume) peritoneal dialysis solution containing L-carnitine (0.25% weight/volume) for the long dwell. Peritoneal dialysis solution was instilled for 5 days.
Long Dwell Ultrafiltration
2167 milliliters
Standard Deviation 203

Adverse Events

Peritoneal Dialysis Solution

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Serious adverse events

Adverse event data not reported

Other adverse events

Adverse event data not reported

Additional Information

Mario Bonomini, M.D.

University G. D'Annunzio

Phone: +39 0871 540120

Results disclosure agreements

  • Principal investigator is a sponsor employee
  • Publication restrictions are in place